MEDI-FIRST
- Product NDC
- 71927-019
- 11-digit product format
- 719270019
- Labeler code
- 71927
- Product ID
- 71927-019_5abd4200-f481-aca6-e063-6294a90ac4bc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Benzalkonium Chloride, Lidocaine
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- Orazen Inc
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-08-29
- Substance
- LIDOCAINE HYDROCHLORIDE; BENZALKONIUM CHLORIDE
- Active strength
- 5; 1.3 mg/g; mg/g
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 71927-019-03 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 71927-019-02 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 71927-019-02 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 71927-019-03 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- MEDI-FIRST
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LIDOCAINE HYDROCHLORIDE | 5 mg/g |
| BENZALKONIUM CHLORIDE | 1.3 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V13007Z41A | Internal UNII lookup |
| F5UM2KM3W7 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1012100 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f508434f-5948-7134-e053-2a95a90a03d7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 860a93dc-4863-49cc-b284-6bbe8191bc48 | Product name | 4 | 20250214 |
| eaba870a-6a9d-442e-8643-87b3f558a451 | Product name | 1 | 20250117 |
| 9b4cf230-fd05-41d5-98c6-5db9ecb27b86 | Product name | 1 | 20230117 |
| fa8b5901-e681-426f-82fe-54f6d81ec698 | Product name | 4 | 20180619 |
| 332d03e4-aa24-4b11-841a-02bf41081920 | Product name | 1 | 20171221 |
| c08ab52f-2fc8-4409-9d9f-ed8edc0bd070 | Product name | 1 | 20171221 |
| 68ed98f8-24c2-44a0-944a-6d36e82ce25a | Product name | 1 | 20141222 |
| 1cd42bc2-a430-c72b-636d-991b235fbf80 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71927-019-01 | MEDI-FIRST | 0.9 g in 1 POUCH | CREAM | 0.9 | 2 | |
| 71927-019-01 | MEDI-FIRST | 0.9 g in 1 POUCH | CREAM | 0.9 | 2 | |
| 71927-019-02 | MEDI-FIRST | 25 in 1 BOX | CREAM | 25 | 2 | |
| 71927-019-03 | MEDI-FIRST | 25 in 1 BOX | CREAM | 25 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71927-019 | MEDI-FIRST (BENZALKONIUM CHLORIDE, LIDOCAINE) CREAM [ORAZEN INC] | 1 | Current NDC, 2 package rows | 20230221_f522fb0b-3d86-b228-e053-2a95a90a55e9.zip |
| 71927-019 | MEDI-FIRST (BENZALKONIUM CHLORIDE, LIDOCAINE) CREAM [ORAZEN INC] | 1 | Current NDC, 2 package rows | 20230220_f508434f-5948-7134-e053-2a95a90a03d7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ULTRA STRENGTH ZHENG GU SHUI | MENTHOL AND CAMPHOR | GUANGXI YULIN PHARMACEUTICAL GROUP CO LTD | 53397663-044d-4e48-989b-2c6257af5f84 | 2025-07-14 | Warnings, Adverse reactions | M017 |
| TIGER BALM PAIN RELIEVING HYDROGEL | CAMPHOR (SYNTHETIC), LEVOMENTHOL, AND CAPSICUM | Haw Par Healthcare Ltd. | cb60037f-bceb-4090-a5e4-bdda0cbf9f5c | 2025-07-14 | Warnings | M017 |
| Avedana Hydrocortisone Cream with Aloe | HYDROCORTISONE | Unipack LLC | 2a55c426-39b4-4d94-b6b4-6c548c9685e9 | 2025-07-13 | Warnings | M017 |
| Hydrocortisone | HYDROCORTISONE ACETATE | Rite Aid Corporation | cb6e0bed-2ea1-49d2-89e7-2554e7565b74 | 2025-07-11 | Warnings | M017 |
| QUALITY CHOICE Maximum Strength Lidocaine Pain Relief Roll On | LIDOCAINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | 7b3ff4c1-0b60-4f7a-8aa4-c84b7c7137c4 | 2025-07-11 | Warnings | M017 |
| Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | TARGET Corporation | 6fba5890-f48f-4302-a8ac-5087a6e03bd5 | 2025-07-11 | Warnings | M017 |
| TopCare Antibiotic Plus Pain Relief | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Topco Associates LLC | 55dc4025-f07f-41b2-8b18-6a11ee04b5cc | 2025-07-11 | Warnings | M017 |
| Benadryl Extra Strength Itch Relief | DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE | Kenvue Brands LLC | 309d9be0-e367-429a-a1fa-ab7855477c8a | 2025-07-10 | Warnings | M017 |
| Bengay Vanishing Scent | MENTHOL, UNSPECIFIED FORM | Kenvue Brands LLC | 6cc3294b-3b0f-44d0-af71-61db1022d269 | 2025-07-10 | Warnings | M017 |
| Cold Hot Medicated Patch 5% Menthol | MENTHOL | Quality Choice | ce544a7c-8dc6-4e63-b499-d8a4e0ec48c3 | 2025-07-10 | Warnings | M017 |
| Hydrocortisone | HYDROCORTISONE ACETATE | Walgreen Company | bff322f1-59c3-41e0-8685-fcfe52bf4b42 | 2025-07-10 | Warnings | M017 |
| CVS Cortisone | HYDROCORTISONE | CVS Pharmacy | 87631be8-94b8-4718-858d-d2f30e636cce | 2025-07-10 | Warnings | M017 |
| TopCare Hydrocortisone Plus 12 Moisturizers | HYDROCORTISONE | Topco Associates LLC | c40e8e1d-d6d7-4880-99d3-011b97a5e4f3 | 2025-07-10 | Warnings | M017 |
| Live Better Hydrocortisone with Aloe | HYDROCORTISONE | The Great Atlantic & Pacific Tea Company | 044e6ee2-98a6-4802-b33d-78b8551356c4 | 2025-07-10 | Warnings | M017 |
| Rocainol TOPICAL ANALGESIC | METHYL SALICYLATE, MENTHOL | Compania Internacional de Comercio, S.A.P.I de C.V. | 827ec7b2-3d87-47e0-a47a-966b25732c32 | 2025-07-10 | Warnings | M017 |
| NumbR-X | LIDOCAINE HCL | Prodigy Media Inc | 16329ab6-4a33-4c38-85e0-5aad9c75d61d | 2025-07-10 | Warnings | M017 |
| Dr Lido | LIDOCAINE HCL | Prodigy Media Inc | da0938f0-00e7-4502-8721-d64c71f594fc | 2025-07-10 | Warnings | M017 |
| Pain Relief Patch | CAMPHOR, METHYL SALICYLATE, MENTHOL | CDMA, Inc. | da1ec2fe-cc37-4126-90a8-6eb4b8f2e57b | 2025-07-09 | Warnings | M017 |
| ORTHOGEL Menthol 3.5% | MENTHOL | LiquidCapsule Manufacturing LLC | 4fd4b7ac-1971-4abe-8fbb-74ab69e12061 | 2025-07-09 | Warnings | M017 |
| Good Neighbor Pharmacy Hydrocortisone Plus 12 Moisturizers | HYDROCORTISONE | AmerisourceBergen | f36acdb8-a526-4bb7-a557-e1dcbbc1cf45 | 2025-07-08 | Warnings | M017 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1012100 | benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream | PSN | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine HCl 0.5 % Topical Cream | PSN | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
| 1012100 | benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream | SCD | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 1.3 MG/ML / lidocaine hydrochloride 5 MG/ML Topical Cream | SCD | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream | SY | f508434f-5948-7134-e053-2a95a90a03d7 | 2 |
| 1012100 | benzalkonium chloride 0.13 % / lidocaine hydrochloride 0.5 % Topical Cream | SY | f522fb0b-3d86-b228-e053-2a95a90a55e9 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 71927-019-01 | 71927001901 | 0.9 g in 1 POUCH | 0.9 g | Historical | |||
| 71927-019-02 | 71927001902 | 25 POUCH in 1 BOX (71927-019-02) / .9 g in 1 POUCH (71927-019-01) | 25 pouch | 2025-08-29 | No | No | Current |
| 71927-019-03 | 71927001903 | 25 POUCH in 1 BOX (71927-019-03) / .9 g in 1 POUCH (71927-019-01) | 25 pouch | 2025-09-03 | No | No | Current |